Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Cytal Wound Matrix 3-Layer

K-Number: K192725 · 2019-10-25

ApplicantAcell, Inc.
Decision Date2019-10-25
Product CodeKGN
DecisionSubstantially Equivalent

Device Summary

Cytal Wound Matrix 3-Layer is a medical device manufactured by Acell, Inc.. It received FDA 510(k) clearance on 2019-10-25 under approval number K192725. The device is classified under product code KGN. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Cytal Wound Matrix 3-Layer?

Cytal Wound Matrix 3-Layer is a medical device that received FDA 510(k) clearance on 2019-10-25. It is manufactured by Acell, Inc.. The 510(k) number is K192725.

When was Cytal Wound Matrix 3-Layer approved by the FDA?

Cytal Wound Matrix 3-Layer received FDA 510(k) clearance on 2019-10-25, under approval number K192725.

What company makes Cytal Wound Matrix 3-Layer?

Cytal Wound Matrix 3-Layer is manufactured by Acell, Inc..

What is the FDA product code for Cytal Wound Matrix 3-Layer?

The FDA product code for Cytal Wound Matrix 3-Layer is KGN.

Related Clinical Trials

Other Devices by Acell, Inc.

View all 11 devices →

Related Devices (Code: KGN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.